Author:
Ferrández Miriam R.,Puertas-Martín Savíns,Redondo Juana L.,Pérez-Sánchez Horacio,Ortigosa Pilar M.
Abstract
AbstractVirtual screening methods focus on searching molecules with similar properties to a given compound. Molecule databases are made up of large numbers of compounds and are constantly increasing. Therefore, fast and efficient methodologies and tools have to be designed to explore them quickly. In this context, ligand-based virtual screening methods are a well-known and helpful tool. These methods focus on searching for the most similar molecules in a database to a reference one. In this work, we propose a new tool called 2L-GO-Pharm, which requires less computational effort than OptiPharm, an efficient and robust piece of software recently proposed in the literature. The new-implemented tool maintains or improves the quality of the solutions found by OptiPharm, and achieves it by considerably reducing the number of evaluations needed. Some of the strengths that help 2L-GO-Pharm enhance searchability are the reduction of the search space dimension and the introduction of some circular limits for the angular variables. Furthermore, to ensure a trade-off between exploration and exploitation of the search space, it implements a two-layer strategy and a guided search procedure combined with a convergence test on the rotation axis. The performance of 2L-GO-Pharm has been tested by considering two different descriptors, i.e. shape similarity and electrostatic potential. The results show that it saves up to 87.5 million evaluations per query molecule.
Funder
Junta de Andalucía
Ministerio de Economía y Competitividad
Universidad de Almería
Comunidad Autónoma de la Región de Murcia
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Mehta, P. et al. COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet 395, 1033–1034 (2020).
2. Geppert, H., Vogt, M. & Bajorath, J. Current trends in ligand-based virtual screening: Molecular representations, data mining methods, new application areas, and performance evaluation. J. Chem. Inform. Model. 50, 205–216 (2010).
3. Puertas-Martín, S. et al. Is high performance computing a requirement for novel drug discovery and how will this impact academic efforts? https://doi.org/10.1080/17460441.2020.1758664 (2020).
4. Bhunia, S. S., Saxena, M. & Saxena, A. K. Ligand- and Structure-Based Virtual Screening in Drug Discovery 281–339 (Springer International Publishing, 2021).
5. Yuriev, E. & Ramsland, P. A. Latest developments in molecular docking: 2010–2011 in review. J. Mol. Recognit. 26, 215–239 (2013).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献